NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 1.3% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 0.86% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 0.83% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 0.81% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 0.81% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 0.8% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 0.8% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 0.8% |
| MAAC | Montes Archimedes Acquisition Corp | Financial Services | Shell Companies | 0.8% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 0.8% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 0.78% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.78% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 0.77% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 0.77% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 0.77% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 0.77% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 0.76% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 0.75% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 0.75% |
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.